Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19. (2023)

First Author: Siggins M
Attributed to:  ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.92695

Publication URI: https://www.repository.cam.ac.uk/handle/1810/345273

Type: Journal Article/Review